58 results match your criteria: "Centre de Recherches Médicales en Lambaréné (CERMEL)[Affiliation]"

Objectives: This wound section of the PREvalence Study on Surgical COnditions (PRESSCO) determines the incidence and prevalence of wounds and burns in Sierra Leone. It further describes access to wound care and wound-related healthcare-seeking behaviour.

Methods: Between October 2019 and March 2020, a nationwide cross-sectional household survey was performed.

View Article and Find Full Text PDF

Malaria poses a serious global health problem, with half the world population being at risk. Regular screening is crucial for breaking the transmission cycle and combatting the disease spreading. However, current diagnostic tools relying on blood samples face challenges in many malaria-epidemic areas.

View Article and Find Full Text PDF

Marburg virus disease outbreak in Rwanda, 2024.

Clin Microbiol Infect

February 2025

Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Disease, Switzerland; High-Level Isolation Unit, Infectious Diseases Unit, La Paz University Hospital, IdiPAZ, CIBERINFEC, Madrid, Spain.

View Article and Find Full Text PDF

Yellow fever breakthrough infections after yellow fever vaccination: a systematic review and meta-analysis.

Lancet Microbe

December 2024

Amsterdam UMC, Location University of Amsterdam, Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health - Global Health, and Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, Netherlands. Electronic address:

Article Synopsis
  • This systematic review and meta-analysis investigated symptomatic yellow fever breakthrough infections in vaccinated individuals, focusing on cases occurring less than and more than ten years after vaccination.
  • The research reviewed 1975 records, ultimately identifying 37 relevant studies that documented 6951 yellow fever cases, with 537 involving vaccinated patients, primarily from Brazil.
  • A total of 33 confirmed or probable breakthrough cases were found, with two patients severely ill and resulting in death, highlighting a need for ongoing surveillance in vaccinated populations.
View Article and Find Full Text PDF

Background: The RTS,S/AS01 malaria vaccine showed lower antibody response and protective efficacy in infants aged 6-12 weeks compared with children aged 5-17 months (for whom this vaccine is recommended). We aimed to study the effect of previous Plasmodium falciparum exposure on the antibody responses to RTS,S/AS01 vaccination in infants and children, and the mediating effect of baseline (including maternal) anti-circumsporozoite protein (CSP) antibodies.

Methods: In this observational study, we included children and infants from six African countries (Burkina Faso, Gabon, Ghana, Kenya, Mozambique, and Tanzania) enrolled in the MAL067 immunology ancillary study of the RTS,S/AS01 phase 3 clinical trial from March 27, 2009, to Jan 21, 2011.

View Article and Find Full Text PDF

Introduction: The uptake trend of a new vaccine is unpredictable and may reflect the quality of introduction process and community acceptance. The objective of this study was to conduct a trend analysis of RTS,S malaria vaccine uptake in the seven pilot regions of Ghana from 2019 to 2022. The findings are envisaged to strengthen malaria vaccine introductions in the future.

View Article and Find Full Text PDF

Seasonal Malaria Chemoprevention consisting of monthly administration of amodiaquine/sulfadoxine-pyrimethamine to children aged 3-59 months during the transmission season could promote SP-resistance. Mutations in dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes were assessed before and after SMC adoption in Burkina Faso. A total of 769 dried blood spots were selected from studies conducted in Nanoro, Burkina Faso, between 2010 and 2020.

View Article and Find Full Text PDF

Introduction: Savannah Region witnessed a decline in measles-rubella (MR) vaccination coverage prior to the measles outbreak in 2022. This study aimed to assess contributory factors of the low routine MR vaccination coverage and proffer recommendations to improve vaccination uptake.

Methods: A cross-sectional study was conducted in two districts (Bole and Central Gonja) of Savannah Region from December 2022 to June 2023.

View Article and Find Full Text PDF

The impact of the RTS,S malaria vaccine on uncomplicated malaria: evidence from the phase IV study districts, Upper East Region, Ghana, 2020-2022.

Malar J

October 2024

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Article Synopsis
  • The RTS,S malaria vaccine has been authorized for use in areas with moderate to high malaria transmission, specifically targeting children aged 12-59 months in Ghana.
  • A study conducted from 2020 to 2022 found that the vaccine reduced uncomplicated malaria cases by 33%, though the rate of malaria incidence averted showed a decline over time.
  • Researchers concluded that the vaccine effectively lowers malaria burden, but decreasing protective immunity as children age highlights the need for better vaccination uptake and malaria control strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Ghana switched from the 2-dose Rotarix to the 3-dose Rotavac rotavirus vaccine in 2020 to improve cost-efficiency and reduce cold chain requirements in childhood immunization programs.
  • A study analyzed vaccination and diarrhea data from 2018 to 2022, finding that the uptake of rotavirus vaccines remained stable and there were no significant differences in vaccination coverage or outpatient department visits for diarrhea before and after the switch.
  • The transition to Rotavac provided expected benefits without negative impact, suggesting that such vaccine switches can be beneficial for other immunizations to lower costs and maintain health outcomes.
View Article and Find Full Text PDF

Dissemination and outcome reporting bias in clinical malaria intervention trials: a cross-sectional analysis.

Malar J

September 2024

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.

Background: Dissemination and outcome reporting biases are a significant problem in clinical research, with far-reaching implications for both scientific understanding and clinical decision-making. This study investigates the prevalence of dissemination- and outcome reporting biases in registered interventional malaria research.

Methods: All malaria interventional trials registered on ClinicalTrials.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the effectiveness and tolerability of the antimalarial drug ganaplacide in combination with lumefantrine solid dispersion (LUM-SDF) for treating uncomplicated falciparum malaria across various age groups in a Phase II clinical trial.
  • The trial consisted of three parts: a run-in phase assessing pharmacokinetic interactions, a regimen comparison in adults and adolescents, and a dosage assessment in children aged 2 to under 12 years.
  • Results indicated that co-administration of ganaplacide and LUM-SDF did not significantly alter drug exposure levels, with both drugs showing adequate exposure for efficacy across different age and weight groups, despite some variability.
View Article and Find Full Text PDF

An assessment of Ghana's pilot of the RTS,S malaria vaccine implementation programme; 2019-2021: a retrospective study.

Malar J

September 2024

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Background: In May 2019, Ghana piloted the introduction of RTS,S malaria vaccine into routine immunization in 42 districts of seven of the 16 regions. The RTS,S malaria vaccine implementation programme (MVIP) post-introduction evaluation (PIE) conducted in Ghana, assessed the immunization system as well as healthcare worker and caregiver experiences during the phase-one rollout but was less expressive on quantitative grading of the respective thematic areas of the vaccine introduction plan. Given the utility of summary statistics in programme evaluation and communication, this follow-up study aimed to provide an overall rating of the country's performance regarding the MVIP .

View Article and Find Full Text PDF

The maternal and child health record book: Time to separate?

Midwifery

November 2024

Department of Infectious Diseases, Center of Tropical Medicine and Travel Medicine, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Amsterdam, the Netherlands; Institute of Tropical Medicine, and German Center of Infectious Diseases (DZIF), University of Tuebingen, Tuebingen, Germany; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Centre de Recherches Médicales en Lambaréné (CERMEL), Lambaréné, Gabon; Masanga Medical Research Unit, Masanga, Sierra Leone.

View Article and Find Full Text PDF

Factors associated with acceleration of clinical development for infectious diseases: a cross-sectional analysis of 10-year EMA registration data.

Lancet Reg Health Eur

August 2024

Amsterdam UMC, Location University of Amsterdam, Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health - Global Health, and Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.

Article Synopsis
  • Clinical trials are essential for determining the safety and effectiveness of drugs and vaccines, but they typically take over ten years; however, recent global health emergencies like COVID-19 have shown that these trials can be accelerated.
  • A study analyzed drugs targeting infectious diseases authorized by the European Medicines Agency from 2012 to 2022, finding a median clinical development time of 7.3 years, but significantly shorter times for COVID-19 (1.3 years) and Ebola (5.5 years).
  • Key factors for faster development included the outbreak context, which reduced time by an average of 5.4 years, and the use of accelerated assessment by the EMA, leading to additional time savings.
View Article and Find Full Text PDF

Post-tuberculosis treatment paradoxical reactions.

Infection

October 2024

Centre for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health-Global Health, Amsterdam Infection and Immunity, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands.

Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon.

View Article and Find Full Text PDF

Background: Despite dengue virus (DENV) outbreak in Gabon a decade ago, less is known on the potential circulation of DENV serotypes in the country. Previous studies conducted in some areas of the country, are limited to hospital-based surveys which reported the presence of some cases of serotype 2 and 3 seven years ago and more recently the serotype 1. As further investigation, we extend the survey to the community of Moyen Ogooué region with the aim to assess the presence of the dengue virus serotypes, additionally to characterize chikungunya (CHIKV) infection and describe the symptomatology associated with infections.

View Article and Find Full Text PDF

Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?

Malar J

May 2024

Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Infection and Immunity, Amsterdam Public Health, Amsterdam UMC, Location University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, Netherlands.

Background: Drug repurposing offers a strategic alternative to the development of novel compounds, leveraging the known safety and pharmacokinetic profiles of medications, such as linezolid and levofloxacin for tuberculosis (TB). Anti-malarial drugs, including quinolones and artemisinins, are already applied to other diseases and infections and could be promising for TB treatment.

Methods: This review included studies on the activity of anti-malarial drugs, specifically quinolones and artemisinins, against Mycobacterium tuberculosis complex (MTC), summarizing results from in vitro, in vivo (animal models) studies, and clinical trials.

View Article and Find Full Text PDF

Introduction: Schistosomiasis is a significant public health concern, especially in Sub-Saharan Africa. Conventional microscopy is the standard diagnostic method in resource-limited settings, but with limitations, such as the need for expert microscopists. An automated digital microscope with artificial intelligence (Schistoscope), offers a potential solution.

View Article and Find Full Text PDF

Objectives: We searched for the most-suitable thermometry method in the low-resource, tropical setting of Sierra Leone, both in terms of accuracy and also patient and user acceptance.

Methods: We conducted a prospective comparative study of different methods of body temperature measurement. Each participant had their temperature taken by four different methods: non-contact infrared temperature (NCIT), axillary, tympanic membrane and rectal measurements.

View Article and Find Full Text PDF

Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis.

Vaccine

March 2024

Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Iocation AMC, University of Amsterdam, Amsterdam, the Netherlands; Institute of Tropical Medicine, and German Center of Infectious Diseases (DZIF), University of Tuebingen, Tuebingen, Germany; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Centre de Recherches Médicales En Lambaréné (CERMEL), Lambaréné, Gabon; Masanga Medical Research Unit, Masanga, Sierra Leone.

Introduction: Ghana witnessed an outbreak of measles in 2022 following the COVID-19 pandemic, and Savannah Region was among the regions severely impacted. The objective of this study was to conduct trend analysis of measles case incidence and measles-rubella (MR) vaccination coverage in the Savannah Region to identify gaps and propose remedial actions to mitigate future outbreaks of vaccine preventable diseases (VPDs).

Methods: Analysis of measles surveillance and measles-rubella vaccination data for 2018-2022 was conducted to assess relationship between immunization coverage and measles case incidence.

View Article and Find Full Text PDF

Arboviruses represent a real public health problem globally and in the Central African subregion in particular, which represents a high-risk zone for the emergence and re-emergence of arbovirus outbreaks. Furthermore, an updated review on the current arbovirus burden and associated mosquito vectors is lacking for this region. To contribute to filling this knowledge gap, the current study was designed with the following objectives: (i) to systematically review data on the occurrence and distribution of arboviruses and mosquito fauna; and (ii) to identify potential spillover mosquito species in the Central African region in the last 30 years.

View Article and Find Full Text PDF

Overcoming publication and dissemination bias in infectious diseases clinical trials.

Lancet Infect Dis

March 2024

Instituto de Microbiologia, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

Non-timely reporting, selective reporting, or non-reporting of clinical trial results are prevalent and serious issues. WHO mandates that summary results be available in registries within 12 months of study completion and published in full text within 24 months. However, only a limited number of clinical trials in infectious diseases, including those done during the COVID-19 pandemic, have their results posted on ClinicalTrials.

View Article and Find Full Text PDF

Background: Aedes albopictus and Aedes aegypti are known for their potential as vectors of dengue (DENV) and chikungunya (CHIKV) viruses. However, entomological surveys are mostly carried out during epidemics. In Gabon where outbreaks of both viruses have occurred, there is no vector control program targeting these arboviruses.

View Article and Find Full Text PDF

Prostration and the prognosis of death in African children with severe malaria.

Int J Infect Dis

September 2023

Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Translational Thematic Unit Malaria, German Center for Infection Research (DZIF), Tübingen, Germany.

Objectives: Malaria is still one of the main reasons for hospitalization in children living in sub-Saharan Africa. Rapid risk stratification at admission is essential for optimal medical care and improved prognosis. Whereas coma, deep breathing, and, to a lesser degree, severe anemia are established predictors of malaria-related death, the value of assessing prostration for risk stratification is less certain.

View Article and Find Full Text PDF